Cudkowicz ME - Search Results

1

A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis.

Cudkowicz ME, Lindborg SR, Goyal NA, Miller RG, Burford MJ, Berry JD, Nicholson KA, Mozaffar T, Katz JS, Jenkins LJ, Baloh RH, Lewis RA, Staff NP, Owegi MA, Berry DA, Gothelf Y, Levy YS, Aricha R, Kern RZ, Windebank AJ, Brown RH Jr. Cudkowicz ME, et al. Muscle Nerve. 2022 Mar;65(3):291-302. doi: 10.1002/mus.27472. Epub 2022 Jan 5. Muscle Nerve. 2022. PMID: 34890069 Free PMC article. Clinical Trial.

2

An update on superoxide dismutase 1 in familial amyotrophic lateral sclerosis.

Cudkowicz ME, Brown RH Jr. Cudkowicz ME, et al. J Neurol Sci. 1996 Aug;139 Suppl:10-5. doi: 10.1016/0022-510x(96)00084-6. J Neurol Sci. 1996. PMID: 8899652 Review. No abstract available.

3

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis.

Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, Schoenfeld DA, Hosler BA, Horvitz HR, Brown RH. Cudkowicz ME, et al. Ann Neurol. 1997 Feb;41(2):210-21. doi: 10.1002/ana.410410212. Ann Neurol. 1997. PMID: 9029070

4

Intrathecal administration of recombinant human superoxide dismutase 1 in amyotrophic lateral sclerosis: a preliminary safety and pharmacokinetic study.

Cudkowicz ME, Warren L, Francis JW, Lloyd KJ, Friedlander RM, Borges LF, Kassem N, Munsat TL, Brown RH Jr. Cudkowicz ME, et al. Neurology. 1997 Jul;49(1):213-22. doi: 10.1212/wnl.49.1.213. Neurology. 1997. PMID: 9222193 Clinical Trial.

5

Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene.

Cudkowicz ME, McKenna-Yasek D, Chen C, Hedley-Whyte ET, Brown RH Jr. Cudkowicz ME, et al. Ann Neurol. 1998 Jun;43(6):703-10. doi: 10.1002/ana.410430604. Ann Neurol. 1998. PMID: 9629839

6

Administration of nitric oxide synthase inhibitors does not alter disease course of amyotrophic lateral sclerosis SOD1 mutant transgenic mice.

Upton-Rice MN, Cudkowicz ME, Mathew RK, Reif D, Brown RH Jr. Upton-Rice MN, et al. Among authors: cudkowicz me. Ann Neurol. 1999 Mar;45(3):413-4. doi: 10.1002/1531-8249(199903)45:3<413::aid-ana24>3.0.co;2-5. Ann Neurol. 1999. PMID: 10072062 No abstract available.

7

The pharmacokinetics and pharmaco-dynamics of Procysteine in amyotrophic lateral sclerosis.

Cudkowicz ME, Sexton PM, Ellis T, Hayden DL, Gwilt PR, Whalen J, Brown RH Jr. Cudkowicz ME, et al. Neurology. 1999 Apr 22;52(7):1492-4. doi: 10.1212/wnl.52.7.1492. Neurology. 1999. PMID: 10227642 Clinical Trial.

8

Increased oxidative damage to DNA in ALS patients.

Bogdanov M, Brown RH, Matson W, Smart R, Hayden D, O'Donnell H, Flint Beal M, Cudkowicz M. Bogdanov M, et al. Free Radic Biol Med. 2000 Oct 1;29(7):652-8. doi: 10.1016/s0891-5849(00)00349-x. Free Radic Biol Med. 2000. PMID: 11033417

9

Comparison of incremental with multipoint MUNE methods in transgenic ALS mice.

Shefner JM, Cudkowicz ME, Brown RH Jr. Shefner JM, et al. Among authors: cudkowicz me. Muscle Nerve. 2002 Jan;25(1):39-42. doi: 10.1002/mus.10000. Muscle Nerve. 2002. PMID: 11754183

10

Disease course unaltered by a single intracisternal injection of BMP-7 in ALS mice.

Dreibelbis JE, Brown RH Jr, Pastuszak KA, Smith ER, Kaplan PL, Cudkowicz ME. Dreibelbis JE, et al. Among authors: cudkowicz me. Muscle Nerve. 2002 Jan;25(1):122-3. doi: 10.1002/mus.1222. Muscle Nerve. 2002. PMID: 11754197 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters